Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity

Indian J Ophthalmol. 2011 Jan-Feb;59(1):73-4. doi: 10.4103/0301-4738.73707.
No abstract available

Publication types

  • Case Reports
  • Comparative Study
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Electroretinography
  • Humans
  • Infant, Newborn
  • Intravitreal Injections
  • Male
  • Retinopathy of Prematurity / diagnosis
  • Retinopathy of Prematurity / drug therapy*
  • Retinopathy of Prematurity / pathology
  • Retinopathy of Prematurity / physiopathology*
  • Severity of Illness Index
  • Time Factors
  • Visual Acuity / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab